Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Connie Kang

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Drugs|July 19, 2021
Infigratinib: First ApprovalConnie Kang
Clinical Drug Investigation|October 1, 2022
AVT02: An Adalimumab BiosimilarConnie Kang
Drugs|February 11, 2022
Maribavir: First ApprovalConnie Kang
Drugs|May 15, 2023
Retifanlimab: First ApprovalConnie Kang
Clinical Drug Investigation|August 12, 2021
Moxetumomab Pasudotox in Hairy Cell Leukaemia: A Profile of Its UseConnie Kang
Paediatric Drugs|June 14, 2024
Alirocumab: Pediatric First ApprovalConnie Kang
Drugs|November 24, 2021
Correction to: Infigratinib: First ApprovalConnie Kang
Drugs|August 10, 2022
Mosunetuzumab: First ApprovalConnie Kang
Drugs|April 25, 2026
Pixavir Marboxil: First ApprovalConnie Kang
Drugs|February 27, 2023
Olutasidenib: First ApprovalConnie Kang
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Drugs|July 19, 2021
Infigratinib: First ApprovalConnie Kang
Clinical Drug Investigation|October 1, 2022
AVT02: An Adalimumab BiosimilarConnie Kang
Drugs|February 11, 2022
Maribavir: First ApprovalConnie Kang
Drugs|May 15, 2023
Retifanlimab: First ApprovalConnie Kang
Clinical Drug Investigation|August 12, 2021
Moxetumomab Pasudotox in Hairy Cell Leukaemia: A Profile of Its UseConnie Kang
Paediatric Drugs|June 14, 2024
Alirocumab: Pediatric First ApprovalConnie Kang
Drugs|November 24, 2021
Correction to: Infigratinib: First ApprovalConnie Kang
Drugs|August 10, 2022
Mosunetuzumab: First ApprovalConnie Kang
Drugs|April 25, 2026
Pixavir Marboxil: First ApprovalConnie Kang
Drugs|February 27, 2023
Olutasidenib: First ApprovalConnie Kang
Pageof 6